Shanghai Wanxiang Pharmaceutical

Shanghai Wanxiang Pharmaceutical is a comprehensive pharmaceutical enterprise based in China, focused on the research, development, and manufacturing of chemical drugs and active pharmaceutical ingredients (APIs). The company maintains a strong presence in the generic drug market, producing a wide range of oral solid dosages and injectable formulations. Its core therapeutic focus includes cardiovascular diseases, anti-infectives, and gastrointestinal disorders. With multiple GMP-certified facilities, the company serves as both a domestic supplier and a contract manufacturer for global markets. It is a subsidiary of the Wanxiang Group, leveraging significant industrial resources to maintain high-volume production capabilities. The company's product portfolio includes essential medicines such as amlodipine and various macrolide antibiotics.